The relationship between podocyte glucose transporters and the development of DKD has been recently reviewed (76), so will not be covered in detail, but it is important to discuss the seemingly conflicting results from podocyte-specific GLUT1-over-expressing (77) and GLUT4-knock-out (75) mice, as both of these models were found to protect against the development of DKD. Here, SLC2A1 is linked to diabetic kidney disease.